# A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease

> **NCT00162032** · PHASE3 · COMPLETED · sponsor: **Lantheus Medical Imaging** · enrollment: 445 (actual)

## Conditions studied

- Kawasaki Disease

## Interventions

- **DRUG:** Sestamibi

## Key facts

- **NCT ID:** NCT00162032
- **Lead sponsor:** Lantheus Medical Imaging
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-12
- **Target enrollment:** 445 (ACTUAL)
- **Last updated:** 2019-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162032, "A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00162032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*